active: true
address:
    address1: 601 BRICKELL KEY DRIVE
    address2: SUITE 1000
    city: MIAMI
    postal_code: '33131'
    state: FL
branding:
    icon_url: https://api.polygon.io/v1/reference/company-branding/c21tdHR4LmNvbQ/images/2025-04-04_icon.jpeg
    logo_url: https://api.polygon.io/v1/reference/company-branding/c21tdHR4LmNvbQ/images/2025-04-04_logo.svg
cik: 0001599298
composite_figi: BBG00X3GQL76
currency_name: usd
description: 'Summit Therapeutics Inc is a biopharmaceutical company that focuses
    on the discovery, development, and commercialization of novel antibiotics for
    serious infectious diseases. Its CDI (Clostridiodes difficile infection) product
    candidate is ridinilazole, an orally administered small molecule antibiotic. It
    has two geographical segments: the United States and the United Kingdom.'
homepage_url: https://www.smmttx.com
list_date: '2015-03-05'
locale: us
market: stocks
market_cap: 19960290076.64
name: Summit Therapeutics Inc. Common Stock
phone_number: 305-203-2034
primary_exchange: XNAS
round_lot: 100
share_class_figi: BBG00X3GQL94
share_class_shares_outstanding: 742665924
sic_code: '2834'
sic_description: PHARMACEUTICAL PREPARATIONS
ticker: SMMT
ticker_root: SMMT
total_employees: 159
type: CS
weighted_shares_outstanding: 742846672
